Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity.

Paietta E, Neuberg D, Richards S, Bennett JM, Han L, Racevskis J, Dewald G, Rowe JM, Wiernik PH; Eastern Cooperative Oncology Group.

Am J Hematol. 2001 Mar;66(3):189-96.

PMID:
11279625
2.

CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.

Yoshida T, Kimura N, Sawada H, Suematsu E, Nagano M, Akiyoshi T, Motomura S, Kikuchi M, Nishimura J, Tamura K.

Intern Med. 1999 Jul;38(7):547-55.

3.

Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.

Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, Lau WH.

Blood. 1997 Jun 15;89(12):4501-13. Review.

4.

CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.

Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S.

Blood. 1997 Sep 15;90(6):2417-28.

5.

CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.

Emile JF, Boulland ML, Haioun C, Kanavaros P, Petrella T, Delfau-Larue MH, Bensussan A, Farcet JP, Gaulard P.

Blood. 1996 Feb 15;87(4):1466-73.

6.

Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.

Yamada O, Ichikawa M, Okamoto T, Park C, Motoji T, Mizoguchi H, Shibuya A.

Br J Haematol. 2001 Apr;113(1):153-60.

PMID:
11328295
7.

CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.

Rakozy CK, Mohamed AN, Vo TD, Khatib G, Long PM, Eilender D, Palutke M.

Am J Clin Pathol. 2001 Aug;116(2):168-76.

PMID:
11488062
8.

Primary nasopharyngeal non-Hodgkin lymphoma and its relationship with Epstein-Barr virus infection.

Zhang B, Zong Y, He J, Zhong B, Lin S.

Chin Med J (Engl). 2003 Jun;116(6):913-7.

PMID:
12877806
9.

T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombination.

Nagano M, Kimura N, Akiyoshi T, Nishimura J, Kozuru M, Okamura J, Katsuno M, Yoshida T, Takeshita M, Tachibana K, Ohshima K, Kikuchi M.

Leuk Res. 1997 Aug;21(8):763-73.

PMID:
9379684
10.

CD7+ stem cell leukemia/lymphoma. Features of a subgroup without circulating blast cells.

Katsuno M, Abe Y, Taguchi F, Yufu Y, Sadamura S, Goto T, Takatsuki H, Nishimura J, Hirata J, Akiyoshi T, et al.

Cancer. 1993 Jul 1;72(1):99-104.

11.

The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.

Dalmazzo LF, Jácomo RH, Marinato AF, Figueiredo-Pontes LL, Cunha RL, Garcia AB, Rego EM, Falcão RP.

Br J Haematol. 2009 Jan;144(2):223-9. doi: 10.1111/j.1365-2141.2008.07457.x. Epub 2008 Nov 11.

PMID:
19016721
12.
13.

Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms.

Liu Q, Ohshima K, Sumie A, Suzushima H, Iwasaki H, Kikuchi M.

Virchows Arch. 2001 Mar;438(3):271-9.

PMID:
11315624
14.

Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification.

Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Suefuji H, Suzumiya J, Harada M, Kikuchi M.

Am J Surg Pathol. 2003 Oct;27(10):1366-74.

PMID:
14508398
15.

Diffuse large B cell lymphoma expressing the natural killer cell marker CD56.

Sekita T, Tamaru JI, Isobe K, Harigaya K, Masuoka S, Katayama T, Kobayashi M, Mikata A.

Pathol Int. 1999 Aug;49(8):752-8.

PMID:
10504545
16.

Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.

Liu XY, Atkins RC, Feusner JH, Rowland JM.

Am J Hematol. 2004 Apr;75(4):251-3.

17.

Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.

Suzuki R, Murata M, Kami M, Ohtake S, Asou N, Kodera Y, Tomonaga M, Masaki Y, Kusumoto S, Takeuchi J, Matsuda S, Hirai H, Yorimitsu mS, Hamajima N, Seto M, Shimoyama M, Ohno R, Morishima Y, Nakamura S.

Int J Hematol. 2003 Jun;77(5):482-9.

PMID:
12841387
18.

Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK.

Child FJ, Mitchell TJ, Whittaker SJ, Calonje E, Spittle M, Crocker J, Russell-Jones R.

Br J Dermatol. 2003 Mar;148(3):507-15.

PMID:
12653743
19.

[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].

Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.

Ai Zheng. 2007 Apr;26(4):418-22. Chinese.

PMID:
17430665
20.

Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation.

Panzer-Grümayer ER, Panzer S, Wolf M, Majdic O, Haas OA, Kersey JH.

J Immunol. 1993 Jul 1;151(1):92-9.

PMID:
7686950

Supplemental Content

Support Center